Showing results (1-10 of 287) with videos related to
Sort By:
Pageof 29
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|June 1, 1991
[Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide]T Schaberg, H LodeImmunitat Und Infektion|August 1, 1992
[Ambulant atypical pneumonia: clinical diagnosis and therapy]T Schaberg, H LodeScandinavian Journal of Infectious Diseases. Supplementum|January 1, 1992
Azithromycin in lower respiratory tract infectionsH Lode, T SchabergBiochemical and Biophysical Research Communications|June 14, 1991
Evidence for a platelet-activating factor receptor on human alveolar macrophagesT Schaberg, H Haller, H LodeThe European Respiratory Journal|October 1, 1996
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosisT Schaberg, K Rebhan, H LodeThe Journal of Antimicrobial Chemotherapy|June 1, 1996
Azithromycin--review of key chemical, pharmacokinetic and microbiological featuresH Lode, K Borner, P Koeppe, et al.Microbial Drug Resistance (Larchmont, N.Y.)|July 1, 1995
Lower respiratory tract infections in the intensive care unit: consequences of antibiotic resistance for choice of antibioticH Lode, T Schaberg, M Raffenberg, et al.The Journal of Antimicrobial Chemotherapy|July 1, 1993
Diagnostic problems in lower respiratory tract infectionsH Lode, T Schaberg, M Raffenberg, et al.The American Review of Respiratory Disease|June 1, 1993
Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cellsT Schaberg, M Rau, H Stephan, et al.The European Respiratory Journal|September 1, 1991
Pulmonary schistosomiasis resembling acute pulmonary tuberculosisT Schaberg, W Rahn, P Racz, et al.Pageof 29